Embark Biotech
About:
Embark Biotech is a biotech company identifying cell surface receptors regulating fat tissue calorie-burning and glucose and lipid uptake.
Website: https://embarkbiotech.com/
Top Investors: BioInnovation Institute
Description:
Embark Biotech is an early-stage biotech company that identifies novel cell surface receptors that physiologically regulate fat tissue calorie-burning and glucose and lipid uptake. The company was founded in 2017 and is headquartered in Copenhagen, Denmark.
Total Funding Amount:
10M DKK
Headquarters Location:
Copenhagen, Hovedstaden, Denmark
Founded Date:
2017-01-01
Contact Email:
contact(AT)embarkbiotech.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2021-09-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai